Collections
United States Code
Title 21
Chapter 9
Subchapter VII
Part C
Subpart 8
fees relating to biosimilar biological products
Learn More
Log In
Sign Up
379j–51
Definitions
379j–52
Authority to assess and use biosimilar biological product fees
379j–53
Reauthorization; reporting requirements